Los Angeles, CA, United States of America

Chi-Lee Charlie Ho

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi-Lee Charlie Ho. Retrieved from https://idiyas.com/inventor/chi-lee-charlie-ho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chi-Lee Charlie Ho: Innovator in Protective Molecules Against Toxins

Introduction

Chi-Lee Charlie Ho is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of infectious diseases and toxin exposure. His innovative work focuses on developing protective molecules against anthrax toxin, showcasing his commitment to advancing medical science.

Latest Patents

Chi-Lee Charlie Ho holds a patent for protective molecules against anthrax toxin. This patent discloses compositions and methods that are useful in the treatment of infectious diseases and exposure to toxins. His work in this area is crucial for enhancing public health and safety.

Career Highlights

Chi-Lee Charlie Ho is affiliated with the University of California, where he continues to engage in groundbreaking research. His dedication to innovation in the medical field has positioned him as a key figure in the fight against infectious diseases.

Collaborations

Chi-Lee Charlie Ho has collaborated with notable colleagues, including Eugene Gillespie and Brian T Chamberlain. These partnerships have further enriched his research and contributed to the development of effective treatments.

Conclusion

Chi-Lee Charlie Ho's work in developing protective molecules against anthrax toxin exemplifies his dedication to improving health outcomes. His contributions to the field of infectious diseases are invaluable and highlight the importance of innovation in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…